Cargando…

SLAMF1 Promotes Methotrexate Resistance via Activating Autophagy in Choriocarcinoma Cells

OBJECTIVE: The acquisition of chemoresistance to methotrexate (MTX) still remains one of the major challenges for choriocarcinoma treatment. Herein, we aimed to evaluate the potential role of Signaling Lymphocytic Activation Molecule Family Member 1 (SLAMF1) as a possible regulator of chemoresistanc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Dazun, Zhang, Yu, Tian, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779304/ https://www.ncbi.nlm.nih.gov/pubmed/33408515 http://dx.doi.org/10.2147/CMAR.S278012

Ejemplares similares

DPP4 Regulates DHCR24-Mediated Cholesterol Biosynthesis to Promote Methotrexate Resistance in Gestational Trophoblastic Neoplastic Cells
por: Yuan, Weijie, et al.
Publicado: (2021)

AKR1C3 Overexpression Mediates Methotrexate Resistance in Choriocarcinoma Cells
por: Zhao, Jing, et al.
Publicado: (2014)

Mechanism of Methotrexate‐sensitivity of Choriocarcinoma Cells in Culture
por: Indue, Takami, et al.
Publicado: (1988)

Negative Regulation of Humoral Immunity Due to Interplay between the SLAMF1, SLAMF5, and SLAMF6 Receptors
por: Wang, Ninghai, et al.
Publicado: (2015)

CRISPR-Mediated Triple Knockout of SLAMF1, SLAMF5 and SLAMF6 Supports Positive Signaling Roles in NKT Cell Development
por: Huang, Bonnie, et al.
Publicado: (2016)

ADAM12 silencing promotes cellular apoptosis by activating autophagy in choriocarcinoma cells
por: Wang, Lin, et al.
Publicado: (2020)

miR-497-5p/SALL4 axis promotes stemness phenotype of choriocarcinoma and forms a feedback loop with DNMT-mediated epigenetic regulation
por: Peng, Zheng, et al.
Publicado: (2021)

Migration of Myeloid Cells during Inflammation Is Differentially Regulated by the Cell Surface Receptors Slamf1 and Slamf8
por: Wang, Guoxing, et al.
Publicado: (2015)

ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma
por: Georgiou, Marina, et al.
Publicado: (2022)

Correction: ATR and CDK4/6 inhibition target the growth of methotrexate-resistant choriocarcinoma
por: Georgiou, Marina, et al.
Publicado: (2022)

SLAMF6 clustering is required to augment T cell activation
por: Dragovich, Matthew A., et al.
Publicado: (2019)

CRISPR-Mediated Slamf1(Δ/Δ) Slamf5(Δ/Δ) Slamf6(Δ/Δ) Triple Gene Disruption Reveals NKT Cell Defects but Not T Follicular Helper Cell Defects
por: Hu, Joyce K., et al.
Publicado: (2016)

Lectin galactoside-binding soluble 3 binding protein mediates methotrexate resistance in choriocarcinoma cell lines
por: Chen, XiaoJing, et al.
Publicado: (2022)

Methotrexate induces DNA damage and inhibits homologous recombination repair in choriocarcinoma cells
por: Xie, Lisha, et al.
Publicado: (2016)

SLAMF6 compartmentalization enhances T cell functions
por: Gartshteyn, Yevgeniya, et al.
Publicado: (2022)

Responses to Microbial Challenges by SLAMF Receptors
por: van Driel, Boaz Job, et al.
Publicado: (2016)

SLAMF6/Ly108 promotes the development of hepatocellular carcinoma via facilitating macrophage M2 polarization
por: Meng, Qi, et al.
Publicado: (2022)

LMP1(+)SLAMF1(high) cells are associated with drug resistance in Epstein-Barr virus-positive Farage cells
por: Yoon, Heejei, et al.
Publicado: (2017)

Forskolin promotes vasculogenic mimicry and invasion via Notch-1-activated epithelial-to-mesenchymal transition in syncytiolization of trophoblast cells in choriocarcinoma
por: Xue, Yan, et al.
Publicado: (2020)

Activity of high-dose cis-platinum (NCI 119875) in combination with vincristine and methotrexate in drug-resistant gestational choriocarcinoma. A report of 17 cases.
por: Newlands, E. S., et al.
Publicado: (1979)

SLAMF1 contributes to cell survival through the AKT signaling pathway in Farage cells
por: Yoon, Heejei, et al.
Publicado: (2020)

Nucleoside transporter-guided cytarabine-conjugated liposomes for intracellular methotrexate delivery and cooperative choriocarcinoma therapy
por: Fei, Weidong, et al.
Publicado: (2021)

Recurrent Metastatic Choriocarcinoma Responsive to Etoposide and Cisplatin with Etoposide, Methotrexate, and Dactinomycin: A Case Report
por: Das, Sunil Kumar, et al.
Publicado: (2022)

SLAMF8 expression predicts the efficacy of anti‐PD1 immunotherapy in gastrointestinal cancers
por: Zhang, Qun, et al.
Publicado: (2021)

The Measles Virus Receptor SLAMF1 Can Mediate Particle Endocytosis
por: Gonçalves-Carneiro, Daniel, et al.
Publicado: (2017)

SLAMF8 Participates in Acute Renal Transplant Rejection via TLR4 Pathway on Pro-Inflammatory Macrophages
por: Teng, Lisha, et al.
Publicado: (2022)

Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma
por: Campbell, Kerry S., et al.
Publicado: (2018)

SLAMF8 Downregulates Mouse Macrophage Microbicidal Mechanisms via PI3K Pathways
por: Romero-Pinedo, Salvador, et al.
Publicado: (2022)

Treatment of multiple myeloma with the immunostimulatory SLAMF7 antibody elotuzumab
por: Einsele, Hermann, et al.
Publicado: (2016)

Clinical impact of serum soluble SLAMF7 in multiple myeloma
por: Ishibashi, Mariko, et al.
Publicado: (2018)

Overexpression of iASPP is required for autophagy in response to oxidative stress in choriocarcinoma
por: Chan, Ka-Kui, et al.
Publicado: (2019)

The Receptor Slamf1 on the Surface of Myeloid Lineage Cells Controls Susceptibility to Infection by Trypanosoma cruzi
por: Calderón, Jossela, et al.
Publicado: (2012)

SAP-Dependent and -Independent Regulation of Innate T Cell Development Involving SLAMF Receptors
por: De Calisto, Jaime, et al.
Publicado: (2014)

Cancer cell-expressed SLAMF7 is not required for CD47-mediated phagocytosis
por: He, Yuan, et al.
Publicado: (2019)

The Minor Variant of the Single-Nucleotide Polymorphism rs3753381 Affects the Activity of a SLAMF1 Enhancer
por: Putlyaeva, L.V., et al.
Publicado: (2017)

Vulva choriocarcinoma
por: Boufettal, Houssine
Publicado: (2016)

Vulva choriocarcinoma
por: Boufettal, Houssine, et al.
Publicado: (2016)

Insulin reverses choriocarcinoma 5- fluorouracil resistance
por: Shan, Ying, et al.
Publicado: (2021)

Retreatment of chemotherapy-resistant metastatic choriocarcinoma with immunotherapy
por: Wong, Adriana J., et al.
Publicado: (2022)

Metastasis of Testicular Choriocarcinoma in the Stomach, Complicated by the Development of Choriocarcinoma Syndrome
por: Podzolkov, Valery I., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3lgebb71pi2p0sk9g4s9atk8ug